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Abstract
Background: 5-Aminolevulinic acid (ALA) is a precursor of heme that is fundamentally important in aerobic energy
metabolism. Among the enzymes involved in aerobic energy metabolism, cytochrome c oxidase (COX) is crucial. In
this study, the effect of ALA on cytochrome c oxidase activity was measured.
Findings: c57BL/6N species of mice were administered ALA orally for 15 weeks. After ALA administration, mice
were sacrificed and livers were obtained. COX activity in mitochondria from ALA-administered mouse livers was
1.5-fold higher than that in mitochondria from PBS-administered mouse livers (P < 0.05). Furthermore, ATP levels in
ALA-administered mouse livers were much higher than those in PBS-administered mouse livers. These data suggest
that oral administration of ALA promotes aerobic energy metabolism, especially COX activity.
Conclusions: This is the first report of a drug that functions in aerobic energy metabolism directly. Since COX
activity is decreased in various diseases and aging, the pharmacological effects of ALA will be expanding.
Backgrounds
The activity of cytochrome c oxidase (complex IV, COX,
EC 1.9.3.1) in the electron transfer chain is fundamen-
tally important in aerobic energy metabolism. This
enzyme catalyzes electron transfer from cytochrome c to
molecular oxygen, reducing the latter to water, and
yields substantial energy that drives the formation of a
proton gradient that is then employed to synthesize
ATP [1]. The activity of COX is also important in aging
and several diseases. Age-related decreases in COX
activity have also been reported in many species (e.g.,
Drosophila melanogaster [2], housefly [3], rodents [4,5]).
Müller-Höcker observed that COX-negative muscle
fibers were increased with age in humans and animals
[6-8], showing that the improvement of COX activity is
important for anti-aging. COX activity has been shown
to be diminished in mitochondria from the brains of
Alzheimer’s disease patients [9,10]. In human cancer
cells, p53 regulates COX activity through synthesis of
cytochrome c oxidase 2 (SCO2) [11], causing a metabolic
change called the Warburg effect [12]. COX activity is
a l s oi n h i b i t e db yn i t r i co x i d e( N O ) ,w h i c hi sas i g n a l i n g
molecule involved in many pathophysiological processes
(e.g., smooth muscle relaxation, inflammation, neuro-
transmission, apoptosis) [13]. COX inhibition is also
observed in diabetes. COX levels in sensory neurons
from diabetic rats was downregulated by 29% compared
to that from normal rats [14], and advanced glycation
end products, which are implicated in diabetic complica-
tions, inhibit COX activity by inducing the expression of
inducible nitric oxide synthase (iNOS) [15]. Therefore,
COX activity is important, and to our knowledge there
is no drug that activates COX.
5-Aminolevulinic acid (ALA) is widely distributed in
both plant and animal cells, and it is the common pre-
cursor of tetrapyrrole compounds. In animal cells,
A L Ai sf o r m e df r o mg l y c i n ea n ds u c c i n y lC o Ab yA L A
synthase in mitochondria. Administration of ALA
enhances the cancer-specific accumulation of porphyr-
ins. ALA-induced porphyrins can be fluoresced and
visualized in neoplastic regions. This technique exploits
ALA-induced differences in fluorescent signatures
between normal and cancer tissues. Therefore, the tech-
nique is generally termed fluorescence diagnosis or
photodynamic diagnosis [16].
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inserted into porphyrin to form heme in mitochondria,
which is incorporated into hemoproteins and cyto-
chromes. Because COX and its substrate (cytochrome c)
are major hemoproteins, heme is fundamentally impor-
tant to COX activity. In this study, to increase COX
activity, ALA was administered to mice, and COX activ-
ity in the liver was measured.
Materials and methods
Materials
5-Aminolevulinic acid hydrochloride was purchased
from Cosmo Bio Co., Ltd. (Tokyo, Japan). Mitochondria
isolation and cytochrome c oxidase assay kits were pur-
chased from Sigma Aldrich (St. Louis, MO, USA), and
an ATP assay kit for animal tissues (TA100, Toyo B
Net, Tokyo, Japan) was purchased from Wako Pure
Chemical Industries Ltd. (Osaka, Japan)
Animals and in vivo experiments
c57BL/6N mice (female, 6 weeks old) were purchased
from CREA Japan (Tokyo, Japan). All mice were housed
a n du s e df o re x p e r i m e n t si na ccordance with standard
ethical guidelines for the care and use of laboratory ani-
mals [Science Council of Japan; Guidelines for Proper
Conduct of Animal Experiments (2006)], and this study
was approved by the Animal Experiment Ethics Com-
mittee of Shizuoka Cancer Center.
ALA was administered orally for 15 weeks. As a stock
solution, 4 mg/ml ALA in PBS was prepared, and the
ALA stock solution was added to create a 1:100 dilution
(final concentration: 0.04 mg/ml, approximately 10 mg/
kg/day). PBS was added to drinking water for the con-
trol group.
Measurement of COX activity in liver mitochondria
Mouse livers were extracted,a n dl i v e rm i t o c h o n d r i a
were obtained using a mitochondria isolation kit
(Sigma-Aldrich). In brief, fresh livers were washed and
homogenized (rotor-stator homogenizer (T10 basic
Ultra-Turrax
®, IKA, Staufen, Germany) at 15,000 rpm)
in extraction reagent. The homogenate was centrifuged
at 600 ×g for 5 min, and then the supernatant was
further centrifuged at 11,000 × g for 10 min. The pellet
was suspended in storage buffer and used as a mito-
chondrial fraction. Protein concentrations were deter-
mined by the Bradford assay (Bio-Rad Laboratories,
CA). COX activity in liver mitochondria was measured
using a cytochrome c oxidase assay kit. In brief, 5 μgo f
the mitochondrial fraction were diluted with enzyme
dilution buffer containing 1 mM n-dodecyl b-d-malto-
side. Ferrocytochrome c (reduced cytochrome c with
dithiothreitol) was then added to the sample, and COX
activity was measured by the decrease in absorption at
550 nm. The difference in extinction coefficients
between reduced and oxidized cytochrome c is 21.84 at
550 nm [17]. One unit of COX activity was defined as
the oxidization of 1.0 μmole of ferrocytochrome c per
min at pH 7.0 at 25°C.
Western blot analysis
Western blot analysis was performed as previously
described with some modifications [18]. Liver mitochon-
dria, obtained as described above, were separated by 15%
SDS-PAGE and then transferred onto polyvinylidene
fluoride membranes (Millipore, Bedford, MA). After
incubating in 5% nonfat dry milk in TBST (25 mM Tris,
pH 7.5, 150 mM NaCl, and 0.1% Tween 20) at room tem-
perature for 1 h, the membranes were incubated for 1 h
with mouse anti-COX IV-1 antibody (1:200 dilution in
TBST with 5% nonfat dry milk,S a n t aC r u zB i o t e c h n o l -
ogy, Santa Cruz, CA) followed by incubation in a second-
ary anti-mouse IgG coupled to horseradish peroxidase
(1:3000 dilution in TBST, Cell Signaling, Danvers, MA).
Target proteins were detected using an ECL kit (GE
Healthcare, UK), and the image was captured using an
LAS-4000 imager (GE Healthcare).
Measurement of ATP level in liver
For measuring ATP, cellular ATP in livers was extracted
using an ATP extraction kit of an ATP assay kit
(TA100, Toyo B Net). In brief, small pieces of livers
(about 0.1 g) were washed once with PBS, resuspended
in ATP extraction reagent, and then centrifuged at
1,000 ×g for 10 min. The supernatant was used for the
ATP assay. The ATP level was quantitatively measured
using an ATP assay kit with luciferin and luciferase
according to the protocol provided by the manufacturer
(Toyo B Net).
Results and discussion
No mice died due to ALA administration for 15 weeks,
and significant body weight changes were not observed,
indicating that ALA has no toxicity in this condition.
Western blot analysis of the mouse liver mitochondrial
fraction was performed (Figure 1). COX consists of 10
 
Figure 1 Western blot analysis of the mouse liver
mitochondrial fraction. Ten micrograms of liver mitochondria,
obtained as described in the Material and Methods section, were
separated by 15% SDS-PAGE and then electrotransferred on to a
PVDF membrane and Western blot analysis were performed using
COX IV-1 antibody. The average COX IV expression level in the ALA
administered group was 1.6-fold higher than that of the control
group.
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coded subunits [19]. Among these 13 subunits, subunit
IV specifically binds ATP, playing an important role in
COX activity [20]. Thus the antibody raised against
COX IV was employed for western blot analysis in our
study (Figure 1). Apparent increases in COX protein
levels were observed in ALA-administered mouse livers.
Approximately 1.6-fold increase was observed by densi-
tometric scanning compared to the control.
Figure 2 illustrates COX activity in mitochondria from
mouse livers. COX activity was defined as the oxidiza-
tion of ferrocytochrome c. The average COX activity in
mitochondria from ALA-administered mouse livers was
1.5-fold higher than that in mitochondria from control
mouse livers, which was statistically different (P < 0.05
by Student’s t-test). This finding is in good agreement
w i t ht h ei n c r e a s ei nC O Xp r o t e i nl e v e l s ,a ss h o w ni n
Figure 1. COX activity in Drosophila melanogaster
declined progressively with age by 33% [2], indicating
that the 1.5-fold increase in activity observed in this
study is substantial. Our results clearly demonstrate that
both COX protein levels and activity were increased by
ALA administration. This is the first report of hepatic
COX activation achieved by oral administration of a nat-
ural compound.
Figure 3 shows ATP levels in mouse liver lysates. ATP
was extracted and quantified using luciferin and lucifer-
ase. ATP levels in ALA administered mouse livers were
1.6-fold higher than those in control mouse livers. This
apparent increase in ATP levels may be caused by COX
activation in the mitochondrial electron transfer chain.
COX and cytochrome c are hemoproteins, and COX
activity was increased by ALA administration. ALA is
the precursor of protoporphyrin, and heme is produced
by the insertion of iron. Therefore, ALA administration
can result in heme production in the mouse liver, and it
is possible that COX activity was increased by ALA
administration. Heme deficiency selectively decreased
the activity and protein content of COX by 95% [21],
that is observed in aging. This phenomenon strongly
suggests the amount of heme is important for the COX
activity. In addition, COX requires some cofactors,
namely iron and copper ions. In this study, iron and
copper were not administrated directly. However, these
elements were easily obtained by the animals via routine
feeding. There is a possibility that these elements have
key roles in the maintenance of COX following adminis-
tration of ALA. Because we detected increases in COX
activity and protein levels, further analysis may be
needed for clarification. In addition to COX, Complex II
and Complex III are also hemoproteins. These proteins
may also be upregulated by ALA administration.
Coenzyme Q10 (CoQ10) is also a well-known cofactor
in the aerobic respiratory electron transfer and is widely
used as a nutritional supplement. Orally administrated
CoQ10 can be taken up by mitochondria, but only to a
limited extent [22,23]. On the other hand, protopor-
phyrin and heme are generated in mitochondria after
ALA administration. This active targeting is important
in ALA-mediated COX activation.
ALA is used in various fields, especially cancer diagno-
sis and therapy. There is no report of toxic side effects
caused by ALA administration. In the present study, no
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Figure 2 COX activity in mitochondria from mouse livers.C O X
activity was defined as the oxidization of ferrocytochrome c. Bars
represent SD of the means of three replicate experiments. *P < 0.05
by Student’s t-test.
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Figure 3 ATP level in mouse liver lysates. ATP was extracted and
quantified using luciferin and luciferase. Bars represent SD of the
means of three replicate experiments. P = 0.069 by Student’s t-test.
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tion, indicating its safety. Moreover, ALA supplementa-
tion has been used in several fields to date. Wang et al.
demonstrated that ALA and vitamin C supplementation
improved iron status including hemoglobin levels in
sows and laying hens [24,25]. Yamazaki et al. revealed
that ALA and iron ion administration caused a stimula-
tory effect on hair growth [26]. These findings strongly
suggest that ALA is a potentially useful nutritional
supplement.
In conclusion, we demonstrated improvement of COX
activity by ALA administration, suggesting the further
potential benefits of ALA. If ALA activates COX activ-
ity, ALA would be a promising candidate of treatment
option for aging, diabetes, Alzheimer’s disease, chronic
inflammation, and cancers.
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